Loading…
Medicare IVIG Access Enhancement Act of 2023
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
446d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Health Issues
H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma- derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.
Client expense: Not reported · Firm income: $80,000
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R. 6465 & S. 4741, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.
Client expense: $410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
H.R. 6465, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 5818, Medicare IVIG Access Enhancement Act of 2023. H.R. 4438, John W. Walsh Alpha-1 Home Infusion Act of 2023.
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Environment/Superfund
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Veterans
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Veterans
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Environment/Superfund
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Environment/Superfund
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Veterans
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy (VET); EPA regulation of medical device sterilization (ENV); FDA review of imported medical devices (HCR)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Environment/Superfund
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); EPA regulation of medical device sterilization (ENV)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medicare/Medicaid
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); EPA regulation of medical device sterilization (ENV)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Veterans
Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 5818; S 3132) (MMM); Veterans access to innovative medical technologies (VET); EPA regulation of medical device sterilization (ENV)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| CA |